ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clinical Microbiology and Infection, vol.18, pp.19-37, 2012. ,
DOI : 10.1111/1469-0691.12039
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-535, 2009. ,
DOI : 10.1086/596757
Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital, Medical Mycology, vol.49, issue.2, pp.346-354, 2010. ,
DOI : 10.1111/j.1439-0507.2006.01198.x
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007), Cancer, vol.5, issue.20, pp.4745-4752, 2001. ,
DOI : 10.3201/eid1006.030873
blood stream infections in patients with hematological malignancies or solid tumors, Medical Mycology, vol.91, issue.1, pp.50-55, 2012. ,
DOI : 10.1128/JCM.00920-10
A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies, Clinical Microbiology and Infection, vol.20, issue.1, pp.50-57, 2014. ,
DOI : 10.1111/1469-0691.12312
Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031), Clinical Infectious Diseases, vol.61, issue.3, pp.324-331, 2015. ,
DOI : 10.1056/NEJMoa066906
Characteristics of candidemia in oncology differ from those in hematology: a prospective study over a decade, 2016. ,
Dromer F, on behalf of the French Mycosis Study Group (2017) Predispos? ing factors and outcome of uncommon yeast species?related fungaemia based on an exhaustive surveillance programme, J Antimicrob Chemother, 2002. ,
ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, pp.532-538, 2011. ,
DOI : 10.1128/AAC.01128-10
EUCAST?AFST (2015) EUCAST technical note on the EUCAST definitive document EDef 7.3: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts, 2017. ,
, Flucona? zole: rationale for the clinical breakpoints, version 2, European Committee on Antibiotic Susceptibility Testing, 2013.
Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing, European Committee on Antibiotic Susceptibility Testing, pp.3092-3098, 2008. ,
DOI : 10.1128/AAC.00088-08
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain, Clinical Microbiology and Infection, vol.20, issue.4, pp.245-254 ,
DOI : 10.1111/1469-0691.12380
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001???2006: Overview of the Transplant???Associated Infection Surveillance Network (TRANSNET) Database, overview of the Transplant?Associated Infection Surveillance Network (TRANSNET) Database, pp.1091-1100, 2001. ,
DOI : 10.1086/651263
Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001???2010, International Journal of Antimicrobial Agents, vol.40, issue.6, pp.533-538, 2001. ,
DOI : 10.1016/j.ijantimicag.2012.07.022
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM?2004 study, Haema? tologica, vol.91, pp.1068-1075, 2006. ,
Population?based analysis of invasive fungal infections, Emerg Infect Dis, vol.20, pp.1149-1155, 2001. ,
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population? based surveillance, Barcelona Candidemia Project Study Group J Clin Microbiol, vol.43, pp.1829-1835, 2002. ,
The changing epidemiology of invasive candidiasis, Cancer, vol.37, issue.11, pp.2493-2499, 2008. ,
DOI : 10.3201/eid1006.030873
Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry, Clinical Infectious Diseases, vol.48, issue.12, pp.1695-1703, 2009. ,
DOI : 10.1086/599039
Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital, Clinical Microbiology and Infection, vol.17, issue.10, pp.1538-1545, 2011. ,
DOI : 10.1111/j.1469-0691.2010.03338.x
Epidemiology of Candida kefyr in Patients with Hematologic Malignancies, Journal of Clinical Microbiology, vol.52, issue.6, pp.1830-1837, 2014. ,
DOI : 10.1128/JCM.00131-14
Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007, Diagnostic Microbiology and Infectious Disease, vol.64, issue.3, pp.289-294, 2004. ,
DOI : 10.1016/j.diagmicrobio.2009.03.010
in the Intensive Care Unit, Clinical Infectious Diseases, vol.9, issue.8, pp.1206-1213, 2008. ,
DOI : 10.1007/s10096-002-0822-1
Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain, Clinical Microbiology and Infection, vol.16, issue.11, pp.1676-1682, 2010. ,
DOI : 10.1111/j.1469-0691.2010.03208.x
Risk factors and outcomes of Candida krusei bloodstream infection: A matched, case-control study, Journal of Infection, vol.66, issue.3, pp.278-284, 2013. ,
DOI : 10.1016/j.jinf.2012.11.002
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death, Journal of Antimicrobial Chemotherapy, vol.13, issue.10, pp.1042-1051 ,
DOI : 10.3109/13693780802549594
Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC), Clinical Infectious Diseases, vol.28, issue.5, pp.1071-1079, 1999. ,
DOI : 10.1086/514731
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study, Annals of Intensive Care, vol.29, issue.12, 2016. ,
DOI : 10.1007/s00134-003-2002-x
URL : https://hal.archives-ouvertes.fr/hal-01259216
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials, Clinical Infectious Diseases, vol.51, issue.3, pp.1110-1122, 2012. ,
DOI : 10.1086/653935
Epidemiology and Prognostic Factors of Candidemia in Cancer Patients, PLoS ONE, vol.61, issue.6, p.99103, 2014. ,
DOI : 10.1371/journal.pone.0099103.t003
URL : https://doi.org/10.1371/journal.pone.0099103
Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011, Clinical Infectious Diseases, vol.49, issue.2, pp.1352-1361, 2008. ,
DOI : 10.3109/13693786.2010.512300
URL : https://academic.oup.com/cid/article-pdf/55/10/1352/922240/cis697.pdf
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data, Intensive Care Medicine, vol.18, issue.11, pp.1931-1940, 2015. ,
DOI : 10.1186/cc13953
URL : https://hal.archives-ouvertes.fr/hal-01205360
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study, BMC Infectious Diseases, vol.12, issue.1, p.150, 2010. ,
DOI : 10.1186/cc6212
URL : http://doi.org/10.1186/1471-2334-10-150
Treatment-related risk factors for hospital mortality in Candida bloodstream infections*, Critical Care Medicine, vol.36, issue.11, pp.2967-2972, 2008. ,
DOI : 10.1097/CCM.0b013e31818b3477
Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with Candidemia, Antimicrobial Agents and Chemotherapy, vol.51, issue.1, pp.35-39, 2007. ,
DOI : 10.1128/AAC.00474-06
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control, Clinical Infectious Diseases, vol.331, issue.20, pp.1739-1746, 2012. ,
DOI : 10.1056/NEJM199411173312001
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi???Institutional Study, Clinical Infectious Diseases, vol.1, issue.1, pp.25-31, 2006. ,
DOI : 10.1099/jmm.0.45856-0